Skip to main content

Advertisement

Log in

Expression and role of V1A subunit of V-ATPases in gastric cancer cells

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

Vacuolar-ATPases (V-ATPases) play an important role in maintaining a relatively neutral pHi (internal pH) and are responsible for the progression of cancer. V-ATPases contain different subunits and few studies have been conducted on subunit V1A. This study aimed to investigate the gene expression of V1A subunit of V-ATPases in gastric cancer tissues and explore its role in the progression and prognosis of gastric cancer.

Methods

The protein expressions of the V1A subunit of V-ATPase gene in 100 normal gastric specimens and 100 gastric cancer tissues were determined by immunohistochemistry. The role of V1A subunit of V-ATPases was studied using a specific small interfering RNA (siRNA).

Results

The positive expression rate of the V1A subunit of V-ATPases was 76 % in gastric cancer tissue samples, much higher than that in normal tissue samples (30 %, P < 0.05), and was correlated with histological grade (P = 0.001), lymph node metastasis (P = 0.002), TNM (P = 0.040), and vascular invasion (P = 0.010), but not with patient age, sex, depth of tumor invasion, tumor size, or histological type. The median overall survival times of 76 patients who had positive staining for tumor cell V1A subunit of V-ATPases and 24 patients who had negative staining were 31.7 and 59.2 months, respectively. When the expression of V1A subunit was knocked down using siRNA, the proliferation and invasion of gastric cancer cells in vitro were significantly inhibited.

Conclusions

V1A subunit of V-ATPases can be a prognostic indicator for poor outcome and is a therapeutic target in gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108

    Article  PubMed  Google Scholar 

  2. Ushijima T, Sasako M (2004) Focus on gastric cancer. Cancer Cell 5:121–125

    Article  CAS  PubMed  Google Scholar 

  3. Kapadia CR (2003) Gastric atrophy, metaplasia, and dysplasia: a clinical perspective. J Clin Gastroenterol 36:S29–S36

    Article  PubMed  Google Scholar 

  4. Hinton A, Bond S, Forgac M (2009) V-ATPase functions in normal and disease processes. Pflugers Arch—Eur J Physiol 457:589–598

    Article  CAS  Google Scholar 

  5. Perez-Sayans M, Suarez-Penaranda JM, Barros-Angueira F et al (2012) An update in the structure, function, and regulation of V-ATPases: the role of the C subunit. Braz J Biol 72:189–198

    Article  CAS  PubMed  Google Scholar 

  6. Petzoldt AG, Gleixner EM, Fumagalli A et al (2013) Elevated expression of the V-ATPase C subunit triggers JNK-dependent cell invasion and overgrowth in a Drosophila epithelium. Dis Model Mech 6:689–700

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Sermoune SR, Bakunis K (2004) Vacuolar H+-ATPase in human breast human cancer cells with distinct metastatic potential: distribution and functional activity. Am J Physiol Cell Physiol 286:C1443–C1452

    Article  Google Scholar 

  8. Sasazawa Y, Futamura Y, Tashiro E et al (2009) Vacuolar H+-ATPase inhibitors overcome Bcl-xL mediated chemoresistance through restoration of a caspase-independent apoptotic pathway. Cancer Sci 100:1460–1467

    Article  CAS  PubMed  Google Scholar 

  9. De Milito A, Fais S (2005) Tumor acidity, chemoresistance and proton pump inhibitors. Future Oncol 1:779–786

    Article  CAS  PubMed  Google Scholar 

  10. Hurtado-Lorenzo A, Skinner M, El Annan J et al (2006) V-ATPase interacts with ARNO and Arf6 in early endosomes and regulates the protein degradative pathway. Nat Cell Biol 8:124–136

    Article  CAS  PubMed  Google Scholar 

  11. Lu X, Qin W, Li J et al (2005) The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump. Cancer Res 65:6843–6849

    Article  CAS  PubMed  Google Scholar 

  12. Hinton A, Bond S, Forgac M (2009) V-ATPase functions in normal and disease processes. Pflugers Arch 457:589–598

    Article  CAS  PubMed  Google Scholar 

  13. Clouston AD (2001) Timely topic: premalignant lesions associated with adenocarcinoma of the upper gastrointestinal tract. Pathology 33:271–277

    Article  CAS  PubMed  Google Scholar 

  14. Lim JH, Park JW, Kim MS et al (2006) Bafilomycin induces the p21-mediated growth inhibition of cancer cells under hypoxic conditions by expressing hypoxia-inducible factor-1alpha. Mol Pharmacol 70:856–865

    Article  Google Scholar 

  15. Hong J, Yokomakura A, Nakano Y et al (2006) Inhibition of vacuolar-type (H+)-ATPase by the cytostatic macrolide apicularen A and its role in apicularen A-induced apoptosis in RAW 264.7 cells. FEBS Lett 580:2723–2730

    Article  CAS  PubMed  Google Scholar 

  16. Wojtkowiak JW, Rothberg JM, Kumar V et al (2012) Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments. Cancer Res 72:3938–3947

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Huss M, Sasse F, Kunze B et al (2005) Archazolid and apicularen: novel specific V1A subunit of V-ATPases inhibitors. BMC Biochem 6:1–13

    Article  Google Scholar 

  18. Pérez-Sayáns M, Somoza-Mart JM, Barros-Angueira F et al (2009) V-ATPases inhibitors and implication in cancer treatment. Cancer Treat Rev 35:707–713

    Article  PubMed  Google Scholar 

  19. Chen M, Zou X, Luo H et al (2009) Effects and mechanisms of proton pump inhibitors as a novel chemosensitizer on human gastric adenocarcinoma (SGC7901) cells. Cell Biol Int 33:1008–1019

    Article  CAS  PubMed  Google Scholar 

  20. De Milito A, Iessi E, Logozzi M et al (2007) Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase independent mechanism involving reactive oxygen species. Cancer Res 67:5408–5417

    Article  CAS  PubMed  Google Scholar 

  21. Dooley CM, Schwarz H, Mueller KP et al (2013) Slc45a2 and V-ATPase are regulators of melanosomal pH homeostasis in zebrafish, providing a mechanism for human pigment evolution and disease. Pigment Cell Melanoma Res 26:205–217

    Article  CAS  PubMed  Google Scholar 

  22. Sennoune SR, Luo D, Martinez-Zaguilan R (2004) Plasmalemmal vacuolar-type H(+)-ATPase in cancer biology. Cell Biochem Biophys 40:185–206

    Article  CAS  PubMed  Google Scholar 

  23. Tabares L, Betz B (2010) Multiple functions of the vesicular proton pump in nerve terminals. Neuron 68:1020–1022

    Article  CAS  PubMed  Google Scholar 

  24. Beyenbach KW, Wieczorek H (2006) The V-type H+ ATPase: molecular structure and function, physiological roles and regulation. J Exp Biol 2009:577–589

    Article  Google Scholar 

  25. Garcia-Garcia A, Perez-Sayans Garcia M, Rodriguez MJ et al (2012) Immunohistochemical localization of C1 subunit of V-ATPase (ATPase C1) in oral squamous cell cancer and normal oral mucosa. Biotech Histochem 87:133–139

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by National Science Foundation Grant No. 81071816. Special thanks to Yong Liu and Junhao Chen for their technical assistance. We also thank Xingyun Xu for collecting materials and references.

Conflict of Interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Weidong Shen.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, P., Chen, H., Han, L. et al. Expression and role of V1A subunit of V-ATPases in gastric cancer cells. Int J Clin Oncol 20, 725–735 (2015). https://doi.org/10.1007/s10147-015-0782-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-015-0782-y

Keywords

Navigation